PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $245,000 | -52.9% | 5,129 | -55.0% | 0.01% | -50.0% |
| Q1 2017 | $520,000 | +21.2% | 11,396 | -14.3% | 0.01% | +27.3% |
| Q4 2016 | $429,000 | -46.7% | 13,291 | -44.3% | 0.01% | -35.3% |
| Q2 2016 | $805,000 | +84.2% | 23,875 | +189.3% | 0.02% | +41.7% |
| Q1 2016 | $437,000 | +47.6% | 8,252 | +114.2% | 0.01% | +140.0% |
| Q4 2015 | $296,000 | +42.3% | 3,853 | -23.9% | 0.01% | +66.7% |
| Q3 2015 | $208,000 | -11.5% | 5,066 | +52.8% | 0.00% | -25.0% |
| Q2 2015 | $235,000 | -51.0% | 3,316 | -38.6% | 0.00% | -60.0% |
| Q1 2015 | $480,000 | +131.9% | 5,397 | +25.3% | 0.01% | +233.3% |
| Q3 2013 | $207,000 | – | 4,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |